Blood Glucose Test Stripes

Blood Glucose Test Strips Market Outlook

The global blood glucose test strips market is projected to reach a valuation of approximately USD 12.5 billion by 2035, exhibiting a compound annual growth rate (CAGR) of around 6.5% throughout the forecast period from 2025 to 2035. This growth is primarily driven by the rising prevalence of diabetes, particularly type 1 and type 2 diabetes, as well as the increasing awareness regarding self-monitoring of blood glucose levels among patients. Additionally, advancements in technology related to diabetes management and the growing demand for non-invasive testing methods are significantly contributing to market expansion. Furthermore, the rising geriatric population, which is more prone to chronic diseases such as diabetes, combined with enhanced healthcare infrastructure and government initiatives promoting diabetes awareness and management, are fostering a favorable market environment. As a result, the blood glucose test strips market is set to experience substantial growth as healthcare systems adapt to the increasing demand for efficient diabetes management solutions.

Growth Factor of the Market

Several factors are propelling the growth of the blood glucose test strips market. Firstly, the increasing incidence of diabetes worldwide is a major growth driver, with the International Diabetes Federation reporting that approximately 463 million adults were living with diabetes in 2019, a figure expected to rise significantly in the coming years. This alarming trend has led to greater demand for blood glucose monitoring devices, including test strips. Furthermore, the rising awareness regarding the benefits of self-monitoring among patients is encouraging more individuals to adopt regular testing as part of their diabetes management plans. Also, advancements in test strip technology, such as the development of more accurate, faster, and easier-to-use strips, are attracting consumers and healthcare providers alike. Additionally, the expansion of distribution channels, including online pharmacies and retail outlets, has increased accessibility to these products, thus fueling market growth. Finally, government support and healthcare reforms focusing on preventive care and management of chronic diseases are creating a conducive environment for the market's expansion.

Key Highlights of the Market

• The blood glucose test strips market is expected to experience robust growth due to the rising prevalence of diabetes globally.
• Technological advancements in glucose monitoring are leading to the development of more efficient and user-friendly test strips.
• Growing awareness regarding diabetes management is driving the demand for self-monitoring devices among patients.
• The expansion of online pharmacies is improving product accessibility for consumers.
• Government initiatives aimed at preventing diabetes and providing better healthcare services are positively impacting the market.

By Product Type

Glucose Oxidase Test Strips:

Glucose oxidase test strips are among the most commonly used strips in diabetes management. These strips utilize the enzyme glucose oxidase to react with glucose present in the blood sample, producing hydrogen peroxide, which subsequently generates an electrochemical signal that is measured by the glucometer. The accuracy and reliability of these test strips have made them a preferred choice for both healthcare professionals and patients. The segment is expected to witness substantial growth as more individuals seek to monitor their blood glucose levels regularly. Additionally, advancements in manufacturing processes are leading to the production of more cost-effective and efficient glucose oxidase strips, further driving their demand in the market.

Glucose Dehydrogenase Test Strips:

Glucose dehydrogenase test strips operate using a different enzymatic reaction compared to glucose oxidase strips. These strips utilize glucose dehydrogenase, which catalyzes the oxidation of glucose to gluconolactone, generating an electrical current that is proportional to the glucose concentration in the blood sample. Due to their superior accuracy and ability to function well under various environmental conditions, glucose dehydrogenase test strips are gaining traction among consumers. Furthermore, as healthcare practitioners increasingly recommend these strips for home monitoring, the segment is poised for significant growth in the coming years.

Glucose Hexokinase Test Strips:

Hexokinase test strips are another option available to diabetes patients. These strips utilize the hexokinase enzyme for glucose quantification, which results in the conversion of glucose to glucose-6-phosphate and the reduction of NAD+ to NADH. This biochemical process produces a measurable electrical signal that correlates with the glucose level in the blood. These test strips are known for their accuracy, and they are often used in clinical settings. Their adoption in home settings is also increasing, which is expected to boost the segment’s growth. Continuous improvements in hexokinase test strip technology are enhancing user experience and driving market demand.

Glucose Mutase Test Strips:

Glucose mutase test strips are less prevalent than the other types but are still an important segment of the market. These strips utilize glucose mutase to catalyze the isomerization of glucose, allowing for effective glucose measurement. They are particularly known for their stability and reliability in different testing environments. While currently a smaller segment, the growing interest in diverse metabolic pathways and their unique advantages could lead to increased adoption in specialized settings, potentially bolstering their market share in the future.

Glucose Electrode Test Strips:

Glucose electrode test strips are innovative devices that incorporate the use of an electrode to measure the glucose concentration in blood samples. These strips offer rapid results and high precision, making them popular among patients requiring frequent monitoring. The integration of smart technology with glucose electrode test strips has propelled their acceptance, as many of these strips can connect to mobile applications, allowing users to track and manage their glucose levels more effectively. As technology continues to advance, the glucose electrode test strips segment is expected to see considerable growth in the upcoming years.

By Application

Hospitals:

In hospitals, blood glucose test strips are an essential component of diabetes management protocols, enabling healthcare professionals to perform accurate and timely glucose monitoring for patients. The hospital segment is crucial as it caters to patients requiring constant supervision and monitoring, especially those in critical care situations. Medical staff rely on these test strips to make informed decisions regarding insulin administration and other treatment plans, enhancing the overall quality of patient care. As diabetes prevalence rises, hospitals are expected to increase their purchasing volumes, thus driving growth in this segment.

Clinics:

Clinics also play a vital role in the blood glucose test strips market, as they are often the first point of contact for patients diagnosed with diabetes. Clinics utilize these test strips for routine monitoring and follow-ups, providing essential data to assess treatment efficacy. The growing emphasis on preventive care and early diagnosis of diabetes is increasing the demand for blood glucose monitoring in outpatient settings, further boosting this segment. Additionally, the rise of specialized diabetes clinics is expected to enhance the market as healthcare providers focus on comprehensive diabetes management.

Home Settings:

Home settings represent one of the fastest-growing applications for blood glucose test strips, driven by the increasing trend of self-monitoring among diabetes patients. With the advent of user-friendly glucose meters and test strips, patients can now conveniently monitor their blood glucose levels from the comfort of their homes. This trend has been significantly accelerated due to the COVID-19 pandemic, as patients prefer to minimize hospital visits. The home settings segment is anticipated to witness substantial growth as more individuals adopt self-management practices and healthcare systems shift focus towards empowering patients with self-care tools.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as a significant segment for blood glucose test strips, particularly for patients undergoing surgeries who may have diabetes or glucose management issues. These centers are equipped to handle a variety of procedures, and the ability to monitor patients’ glucose levels during and post-surgery is crucial for optimal surgical outcomes. The growing acceptance of ASCs as viable alternatives to traditional hospital settings is expected to drive demand for blood glucose test strips, as they seek to provide comprehensive healthcare services that include diabetes management.

Diagnostic Centers:

Diagnostic centers are vital for the early detection and management of diabetes, employing blood glucose test strips to provide accurate diagnostic information. These centers often utilize advanced laboratory testing alongside point-of-care tests, enhancing their ability to serve patients effectively. The increasing number of diagnostic facilities, paired with the rising incidence of diabetes, supports robust growth in this segment. As awareness of diabetes and its complications continues to rise, diagnostic centers are expected to play an increasingly prominent role in the blood glucose test strips market.

By Distribution Channel

Retail Pharmacies:

Retail pharmacies are a primary distribution channel for blood glucose test strips, offering patients easy access to these essential monitoring tools. Consumers often prefer purchasing test strips from local pharmacies due to convenience and immediate availability. Retail pharmacies stock a variety of brands and types of test strips, allowing customers to choose based on their specific needs and preferences. The rise in chronic diseases, especially diabetes, is driving the demand for these products in retail settings, leading pharmacies to expand their offerings and promotions aimed at diabetes management.

Online Pharmacies:

Online pharmacies have emerged as an increasingly popular distribution channel, particularly due to their convenience and competitive pricing. Patients can order blood glucose test strips from the comfort of their homes, which is especially beneficial for those with mobility issues or those living in remote areas. The growth of e-commerce and telehealth services has further fueled the demand for online pharmacies, as patients are more inclined to shop online for their healthcare needs. As the trend of digital healthcare continues to grow, the online distribution channel for blood glucose test strips is expected to expand significantly.

Hospital Pharmacies:

Hospital pharmacies are critical in managing blood glucose test strips for inpatients diagnosed with diabetes or at risk of hyperglycemia. These pharmacies ensure that patients have immediate access to test strips as part of their treatment regimen. Hospital pharmacies are also adaptable, often customizing their inventory based on patient needs and emerging trends in diabetes management. As hospitals focus on improving patient care and outcomes, the demand for blood glucose test strips through hospital pharmacies is likely to see robust growth, aligning with the overall increase in diabetes prevalence.

Diabetes Clinics:

Diabetes clinics are specialized facilities dedicated to managing diabetes and related conditions. These clinics utilize blood glucose test strips as part of their comprehensive patient care approach, providing education and resources to empower patients in managing their condition. The growth of diabetes clinics can be attributed to an increasing emphasis on specialized care and patient-centered management strategies. As more patients seek targeted diabetes care, the demand for test strips in diabetes clinics is expected to rise, contributing positively to the overall market growth.

Others:

This category encompasses various other distribution channels, including specialty stores and health and wellness shops, which contribute to the accessibility of blood glucose test strips. While this segment may not be as significant as the aforementioned channels, it plays an essential role in ensuring that test strips are available to consumers in diverse shopping environments. As health-conscious consumers increasingly seek out diabetes management solutions, niche markets are likely to see growth in the demand for blood glucose test strips, helping to further diversify the distribution landscape.

By Technology

Thick Film Technology:

Thick film technology is a traditional approach used in the production of blood glucose test strips. This technology involves depositing a thick film of enzymes and other reagents onto a substrate, which helps in the electrochemical detection of glucose levels in blood samples. The reliability and ease of use associated with thick film technology have maintained its relevance in the market. However, advancements in technology have led to the emergence of newer alternatives that offer enhanced performance, potentially impacting the growth trajectory of thick film technology in the coming years.

Thin Film Technology:

Thin film technology represents a more advanced manufacturing method for blood glucose test strips, utilizing thinner layers of enzymes and conductive materials to achieve rapid and accurate glucose measurement. This technology has gained popularity due to its capacity for miniaturization and cost-effectiveness while maintaining high accuracy. As healthcare providers and patients alike seek more efficient monitoring tools, the demand for thin film technology-based strips is expected to grow significantly, showcasing the benefits of innovation in diabetes management.

Microdot Enzyme Technology:

Microdot enzyme technology is an innovative approach that enhances the performance of blood glucose test strips by using tiny enzyme dots for glucose detection. This technology allows for faster reaction times and improved accuracy, making it increasingly popular among consumers. As more individuals adopt self-monitoring practices, the market for microdot enzyme technology is likely to expand, driven by the higher efficiency and reliability of these test strips compared to conventional options.

Biosensor Technology:

Biosensor technology is at the forefront of blood glucose monitoring innovation, employing biological materials to detect glucose levels in blood samples. This technology offers rapid results, high sensitivity, and improved user experience. Biosensors often provide additional functionalities, such as data connectivity with mobile applications, which appeals to tech-savvy consumers looking for integrated health management solutions. As the demand for advanced glucose monitoring devices continues to rise, biosensor technology is positioned to play an essential role in the future of the blood glucose test strips market.

Photometric Reflectance Technology:

Photometric reflectance technology is a cutting-edge approach that utilizes light measurement to determine glucose concentration in blood samples. This technique offers the advantage of non-invasive testing, which is highly desirable among patients apprehensive about fingerstick blood sampling. Due to its innovative nature, photometric reflectance technology has the potential to capture a significant share of the market as consumers increasingly prioritize convenience and comfort in blood glucose monitoring. Continuous technological advancements in this area are expected to further drive growth in the segment.

By Region

The blood glucose test strips market is witnessing significant growth across various regions, with North America holding a substantial share. The prevalence of diabetes is notably high in this region, with millions of individuals requiring regular monitoring. The rising awareness of diabetes management and the availability of advanced monitoring technologies contribute to market expansion. The North American market is projected to grow at a CAGR of approximately 7% during the forecast period, reflecting a robust increase in demand for blood glucose test strips as healthcare systems evolve to meet the needs of a growing diabetic population.

Europe also presents a lucrative market for blood glucose test strips, driven by the increasing prevalence of diabetes and government initiatives to promote diabetes awareness and management. The region’s focus on healthcare innovation and the presence of established pharmaceutical companies enhance the market's growth prospects. The Asia Pacific region, on the other hand, is expected to experience rapid growth due to the rising incidence of diabetes in countries like China and India, where healthcare access is improving. The Asia Pacific market is anticipated to grow at the highest CAGR, exceeding 8% during the forecast period, as emerging economies invest in healthcare infrastructure and diabetes management solutions.

Opportunities

As the blood glucose test strips market continues to expand, numerous opportunities arise for stakeholders in the industry. One significant opportunity lies in the integration of advanced technologies with existing products. For example, incorporating digital health features into blood glucose monitoring systems can provide users with real-time data, empowering them to take control of their health. The introduction of smartphone applications that sync with glucose meters opens a new avenue for patient engagement, allowing individuals to track their glucose levels, monitor trends, and communicate with healthcare providers more effectively. This intersection of technology and healthcare represents a promising landscape for companies looking to differentiate their offerings and capture market share.

Another promising opportunity is the potential for market expansion in emerging economies. Countries in Asia Pacific, Latin America, and Africa are witnessing a surge in diabetes prevalence, driven by lifestyle changes and urbanization. As these regions develop their healthcare infrastructure, the demand for blood glucose test strips is anticipated to grow considerably. Companies that strategically position themselves in these markets by establishing partnerships with local distributors, investing in educational campaigns, and tailoring their products to meet regional needs stand to gain substantial rewards. Furthermore, addressing barriers to access, such as affordability and availability, can create competitive advantages and foster long-term growth in these emerging markets.

Threats

Despite the promising growth prospects for the blood glucose test strips market, several threats could hinder progress. The rising competition among manufacturers can lead to price wars, affecting profit margins and undermining the quality of products available in the market. As companies strive to lower costs, there is a risk that the quality and accuracy of test strips may be compromised, leading to potential patient safety concerns. Furthermore, as the market becomes saturated with a plethora of brands and products, consumers may face challenges in discerning which products are best suited for their needs and preferences, creating an opportunity for misinformation and negative experiences.

Another significant threat is the regulatory landscape surrounding medical devices, which is becoming increasingly stringent worldwide. Manufacturers must navigate complex regulatory frameworks and ensure compliance with evolving standards, which can lead to delays in product launches and increased costs. Any potential recalls or non-compliance issues can severely damage a company's reputation and affect its market position. Additionally, the growing awareness of non-invasive glucose monitoring technologies could pose a threat to traditional blood glucose test strips, as consumers may opt for more convenient alternatives, potentially impacting sales in the long term.

Competitor Outlook

• Abbott Laboratories
• Roche Diagnostics
• LifeScan, Inc.
• Bayer AG
• Ascensia Diabetes Care
• Dexcom, Inc.
• Terumo Corporation
• Medtronic PLC
• Nova Biomedical
• Acon Laboratories, Inc.
• Homemedics, Inc.
• SD Biosensor, Inc.
• ARKRAY, Inc.
• ForaCare, Inc.
• GlucoRx

The competitive landscape of the blood glucose test strips market is characterized by a mix of established players and emerging companies, all vying for market share in a growing industry. Major companies such as Abbott Laboratories and Roche Diagnostics are at the forefront, leveraging their extensive distribution networks, brand recognition, and innovative products to maintain their leadership positions. These companies invest significantly in research and development to enhance the accuracy, ease of use, and integration of digital health features in their test strips, further solidifying their market dominance. As the demand for advanced diabetes management solutions rises, these industry leaders are well-positioned to capitalize on emerging trends and meet consumer needs effectively.

Additionally, companies like LifeScan, Inc. and Bayer AG are adapting their strategies to cater to the changing dynamics of the market. They are focusing on enhancing their product offerings by integrating technology-driven solutions that improve user experience and overall satisfaction. This includes the development of smart glucose meters and accompanying applications that allow users to track their blood glucose levels and gain insights into their health trends. These innovations are helping to drive customer loyalty and expand their market reach, ensuring they stay competitive in a rapidly evolving landscape.

Emerging players such as Nova Biomedical and Acon Laboratories, Inc. are also making significant strides in the market, offering niche products that cater to specific consumer needs. These companies often focus on affordability and accessibility, appealing to budget-conscious consumers and those seeking convenient solutions for diabetes management. By targeting underserved markets and developing tailored products, these emerging players are carving out their space in the competitive landscape, challenging established brands and contributing to the diversity of the blood glucose test strips market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 GlucoRx
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Bayer AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ARKRAY, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Dexcom, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic PLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ForaCare, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 LifeScan, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Nova Biomedical
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Homemedics, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Roche Diagnostics
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 SD Biosensor, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Terumo Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Abbott Laboratories
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Ascensia Diabetes Care
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Acon Laboratories, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Glucose Test Stripes Market, By Technology
    • 6.1.1 Thick Film Technology
    • 6.1.2 Thin Film Technology
    • 6.1.3 Microdot Enzyme Technology
    • 6.1.4 Biosensor Technology
    • 6.1.5 Photometric Reflectance Technology
  • 6.2 Blood Glucose Test Stripes Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Home Settings
    • 6.2.4 Ambulatory Surgical Centers
    • 6.2.5 Diagnostic Centers
  • 6.3 Blood Glucose Test Stripes Market, By Product Type
    • 6.3.1 Glucose Oxidase Test Strips
    • 6.3.2 Glucose Dehydrogenase Test Strips
    • 6.3.3 Glucose Hexokinase Test Strips
    • 6.3.4 Glucose Mutase Test Strips
    • 6.3.5 Glucose Electrode Test Strips
  • 6.4 Blood Glucose Test Stripes Market, By Distribution Channel
    • 6.4.1 Retail Pharmacies
    • 6.4.2 Online Pharmacies
    • 6.4.3 Hospital Pharmacies
    • 6.4.4 Diabetes Clinics
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Blood Glucose Test Stripes Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Glucose Test Stripes market is categorized based on

By Product Type

• Glucose Oxidase Test Strips
• Glucose Dehydrogenase Test Strips
• Glucose Hexokinase Test Strips
• Glucose Mutase Test Strips
• Glucose Electrode Test Strips

By Application

• Hospitals
• Clinics
• Home Settings
• Ambulatory Surgical Centers
• Diagnostic Centers

By Distribution Channel

• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies
• Diabetes Clinics
• Others

By Technology

• Thick Film Technology
• Thin Film Technology
• Microdot Enzyme Technology
• Biosensor Technology
• Photometric Reflectance Technology

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Roche Diagnostics
• LifeScan, Inc.
• Bayer AG
• Ascensia Diabetes Care
• Dexcom, Inc.
• Terumo Corporation
• Medtronic PLC
• Nova Biomedical
• Acon Laboratories, Inc.
• Homemedics, Inc.
• SD Biosensor, Inc.
• ARKRAY, Inc.
• ForaCare, Inc.
• GlucoRx